The Ministry of Health and Family Welfare has prohibited the manufacture, sale, and distribution for human use of 16 Fixed Dose Combinations (FDCs) with immediate effect across India. The banned products include antibiotics, analgesics, and dermatological preparations.
Background of the Ban
This decision follows directions from the Supreme Court, which mandated a comprehensive review of all FDCs available in the country. In compliance, the Drugs Technical Advisory Board (DTAB) constituted an Expert Committee to examine various FDCs and identify those that are irrational, lack therapeutic justification, or pose risks to human health.
Categories of Banned FDCs
The prohibited combinations span multiple therapeutic categories:
- Penicillin-class antibiotics
- Analgesic and antispasmodic medicines, including a combination of acetylsalicylic acid (aspirin) and ethoheptazine used for mild to moderate pain
- Dermatological preparations, such as skin creams containing Aloe Vera, Allantoin, Alpha Tocopherol Acetate, D-Panthenol, and Vitamin A
Scientific Assessment
Based on the Expert Committee's scientific assessment, the Government took action against these 16 FDCs because they were found to lack therapeutic justification and their continued use was not considered beneficial relative to potential risks. The Ministry emphasized that this action aligns with ongoing efforts to ensure only safe, effective, and scientifically validated medicines are available to the public.
Implementation and Compliance
All State Drug Controllers, regulatory authorities, and enforcement agencies have been directed to ensure strict implementation and compliance. Manufacturers, importers, distributors, and other stakeholders have been advised to take necessary corrective measures to comply with the law.
This ban reinforces the government's commitment to patient safety and evidence-based healthcare, following previous prohibitions of irrational FDCs after detailed scientific reviews.
